BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fakira AK, Devi LA, Kennedy PJ. Novel Application for G Protein-Biased Mu Opioid Receptor Agonists in Opioid Relapse Prevention. Biol Psychiatry 2020;88:896-7. [PMID: 33213702 DOI: 10.1016/j.biopsych.2020.09.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Kelly E, Conibear A, Henderson G. Biased Agonism: Lessons from Studies of Opioid Receptor Agonists. Annu Rev Pharmacol Toxicol 2023;63:491-515. [PMID: 36170657 DOI: 10.1146/annurev-pharmtox-052120-091058] [Reference Citation Analysis]
2 Azzam AAH, Lambert DG. Preclinical Discovery and Development of oliceridine (Olinvyk®) for the Treatment of Post-Operative Pain. Expert Opin Drug Discov 2021. [PMID: 34817313 DOI: 10.1080/17460441.2022.2008903] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Jin Z, Daksla N, Gan TJ. Neurokinin-1 Antagonists for Postoperative Nausea and Vomiting. Drugs 2021;81:1171-9. [PMID: 34106456 DOI: 10.1007/s40265-021-01532-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]